Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Convertible Debt (2017 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Convertible Debt for 3 consecutive years, with $498800.0 as the latest value for Q4 2021.

  • On a quarterly basis, Convertible Debt fell 39.99% to $498800.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $498800.0, a 39.99% decrease, with the full-year FY2021 number at $498800.0, down 39.99% from a year prior.
  • Convertible Debt was $498800.0 for Q4 2021 at Creative Medical Technology Holdings, roughly flat from $498800.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $831140.0 in Q4 2020 to a low of $915.0 in Q4 2017.
  • A 3-year average of $301617.6 and a median of $238025.0 in 2020 define the central range for Convertible Debt.
  • Biggest YoY gain for Convertible Debt was 6.39% in 2021; the steepest drop was 50.72% in 2021.
  • Creative Medical Technology Holdings' Convertible Debt stood at $915.0 in 2017, then skyrocketed by 90734.97% to $831140.0 in 2020, then plummeted by 39.99% to $498800.0 in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Convertible Debt are $498800.0 (Q4 2021), $498800.0 (Q3 2021), and $157150.0 (Q2 2021).